Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-28

Clinical Trial Update: Rivastigmine in Mild Alzheimer's Disease, FMRI Study [NA]

View source ↗

Summary

Completed clinical trial evaluating rivastigmine for mild Alzheimer's disease using functional MRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine (Rivastigmine)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Alzheimer' Disease | NA | Status: COMPLETED